TAK
Takeda Pharmaceutical Co Ltd
17.40$
-0.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Cash Flow
All figures per share in JPY.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116.05 | 16.17 | 166.29 | 240.15 | 169.86 | 213.81 | 321.23 | 356.05 | 311.22 | 226.64 | 329.27 | 324.88 | |
| 165.92 | 125.22 | 109.07 | 115.75 | 128.09 | 186.33 | 177.84 | 184.87 | 211.61 | 230.33 | 237.14 | 224.96 | |
| 12.94 | 9.33 | 9.79 | 11.83 | 10.39 | 9.30 | 11.97 | 13.75 | 19.32 | 22.42 | 22.69 | 22.70 | |
| -0.25 | 19.26 | -42.63 | -16.13 | -25.36 | -24.05 | -63.72 | 53.86 | 6.69 | – | – | – | |
| 166.79 | -169.52 | 18.88 | 8.52 | 33.08 | 30.22 | 87.63 | 31.26 | -8.05 | -81.00 | -18.49 | 62.36 | |
| 69.12 | 53.83 | 71.27 | 81.52 | 69.35 | 69.50 | 75.14 | 58.98 | 201.83 | 152.10 | 118.24 | 129.36 | |
| 58.08 | -45.17 | -417.17 | -59.32 | -1,466.39 | 93.26 | 125.05 | -62.81 | -193.36 | -146.76 | -114.32 | -115.16 | |
| 90.06 | 89.79 | 90.15 | 90.18 | 73.92 | 90.21 | 90.04 | 89.93 | 88.99 | 90.86 | 94.22 | 97.30 | |
| -11.18 | -14.18 | -14.71 | -11.92 | -0.61 | -1.19 | -0.68 | -24.58 | -8.58 | -0.74 | -16.15 | -16.10 | |
| -0.63 | 29.13 | 299.93 | -97.33 | 1,634.87 | -187.11 | -209.88 | -190.37 | -90.79 | 0.48 | -97.90 | 0.34 | |
| -191.38 | -79.20 | 184.44 | -207.34 | 1,523.55 | -320.91 | -345.83 | -339.30 | -225.86 | -112.13 | -234.04 | -154.99 | |
| -6.87 | -129.30 | -83.96 | -29.70 | 210.53 | -20.79 | 104.42 | -36.94 | -100.70 | -23.96 | -22.64 | 65.49 | |
| 46.92 | -37.66 | 95.01 | 158.63 | 100.51 | 144.31 | 246.09 | 297.07 | 109.39 | 74.55 | 211.03 | 195.53 |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.